1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients. (September 2015)

Record Type:
Journal Article
Title:
1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients. (September 2015)
Main Title:
1951 Impact of lapatinib (La) treatment duration and endocrine therapy (ET) addition on the efficacy of primary dual HER2 blockage with La and trastuzumab (T) for HER2+ breast cancer (BC) patients
Authors:
Bando, H.
Masuda, N.
Nakamura, R.
Kondo, N.
Kuroi, K.
Akiyoshi, S.
Ohtani, S.
Toshimi, T.
Inoue, K.
Yanagida, Y.
Ishiguro, H.
Shimizu, S.
Aogi, K.
Amano, S.
Ozaki, S.
Iguchi-Manaka, A.
Kasai, H.
Morita, S.
Kataoka, T.R.
Toi, M.
Abstract:
Is Part Of:
European journal of cancer. Volume 51:(2015)Supplement 3
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Issue Display:
Volume 51, Issue 3 (2015)
Year:
2015
Volume:
51
Issue:
3
Issue Sort Value:
2015-0051-0003-0000
Page Start:
S316
Page End:
Publication Date:
2015-09
Subjects:
Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:
http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:
10.1016/S0959-8049(16)30899-1 ↗
Languages:
English
ISSNs:
0959-8049
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2027.xml